MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-04-2026
QIAGEN N.V. Total Current Liabilities 2011-2026 | QGEN
Annual Total Current Liabilities QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 512 M | 544 M | 1.08 B | 975 M | 1.52 B | 572 M | 951 M | 972 M | 325 M | 308 M | 268 M | 432 M | 337 M | 267 M | 482 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.52 B | 267 M | 636 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.71 B | $ 115.38 | 0.26 % | $ 35.1 B |  USA |
 |
BioNano Genomics
BNGO
|
22.9 M | $ 1.13 | - | $ 6.15 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 15.65 | -2.86 % | $ 168 M |  China |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 16.19 | 0.87 % | $ 863 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.38 | 0.36 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 2.3 | - | $ 10.2 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 23.22 | 0.39 % | $ 645 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 174.38 | -0.74 % | $ 8.64 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 498.0 | 0.91 % | $ 14.4 B | USA |
 |
Danaher Corporation
DHR
|
6.81 B | $ 189.16 | -0.22 % | $ 135 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 121.65 | 0.6 % | $ 19.3 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.37 | 0.34 % | $ 405 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 7.79 | 1.3 % | $ 998 M | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 14.67 | 1.66 % | $ 444 M | USA |
 |
Guardant Health
GH
|
303 M | $ 79.04 | 0.55 % | $ 9.91 B | USA |
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 2.73 | 1.49 % | $ 88.6 K | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.08 | -2.8 % | $ 4.78 M | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 107.7 | 0.83 % | $ 8.88 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 260.87 | -0.02 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
310 M | $ 196.81 | 1.96 % | $ 19.4 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 120.91 | 3.22 % | $ 5.65 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 80.04 | -0.68 % | $ 5.4 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.54 | -2.1 % | $ 273 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 191.24 | -0.15 % | $ 21.2 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.16 | -2.79 % | $ 1.99 B | USA |
 |
Soleno Therapeutics
SLNO
|
61.4 M | $ 52.56 | -0.13 % | $ 2.67 B | USA |
 |
ENDRA Life Sciences
NDRA
|
751 K | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
3.74 M | - | -2.3 % | $ 19.4 M | USA |